Insulin resistance/hyperinsulinemia and reproductive disorders in infertile women

Reproductive Medicine and Biology

Volumn 9, Issue 4, 2010, Pages 185-190

  Sakumoto, Tetsurou ^a   Tokunaga, Yoshimitu ^b   Tanaka, Hideaki ^c   Nohara, Makoto ^a   Motegi, Emi ^a   Shinkawa, Tadahiko ^a   Nakaza, Aritoshi ^a   Higashi, Masahiro ^a  

^a Tomishiro Central Hospital   (Japan)

^b ALBA OKINAWA CLINIC   (Japan)

^c Tanaka Clinic   (Japan)

Author keywords

Hyperinsulinemia; Insulin resistance; Insulin sensitizer; Lifestyle; Reproductive disorders

Indexed keywords

BIGUANIDE; INSULIN; LEPTIN; LUTEINIZING HORMONE; METFORMIN; PLACENTA PROTEIN 14; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANDROGEN SYNTHESIS; ANOVULATION; BLOOD FLOW; DIET; DISEASE ASSOCIATION; DRUG EFFECT; EMBRYO; ENDOMETRIUM; EXERCISE; FEMALE INFERTILITY; FETUS WASTAGE; GRANULOSA CELL; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; NIDATION; OVARY FOLLICLE CELL; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCTIVE HEALTH; REVIEW; THECA CELL;

EID: 78649903382     PISSN: 14455781     EISSN: 14470578     Source Type: Journal    
DOI: 10.1007/s12522-010-0062-5     Document Type: Review

References (73)

1. The National Nutrition Survey in Japan (J-NNS). Tokyo: DAI-ICHI SHUPPAN; 2003.
2. TJ Wilkin LD Voss 2004 Metabolic syndrome: maladaptation to a modern world J R Soc Med 97 511 520 10.1258/jrsm.97.11.511 15520144 (Pubitemid 39524201)
3. GA Colditz WC Willett A Rotnitzky JE Manson 1995 Weight gain as a risk factor for clinical diabetes mellitus in women Ann Intern Med 122 481 486 1:STN:280:DyaK2M7nslCguw%3D%3D 7872581
4. JM Chan EB Rimm GA Colditz MJ Stampfer WC Willett 1994 Obesity, fat distribution, and weight gain as risk factor for clinical diabetes in men Diabetes Care 17 961 969 1:STN:280:DyaK2M%2FnvF2gtg%3D%3D 10.2337/diacare.17.9. 961 7988316
5. Enzi G, Busetto L, Carraro R. Association of multiple risk factors for cardiovascular disease and visceral obesity. A deadly quartet or sextet? In: Ditshumheit H, et al., editors. Obesity in Europe. London: Libbey; 1994. p. 411-8.
6. RM Sharpe S Franks 2002 Environment, lifestyle and infertility-an inter-generational issue Nat Cell Biol 4 Suppl 33 40 10.1038/ncb-nm-fertilityS33
7. IF Stein ML Leventhal 1935 Amenorrhea associated with bilateral polycystic ovaries Am J Obstet Gynecol 29 181 191
8. JE Nestler D Stovall N Akhter MJ Juorno DJ Jakubowics 2002 Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome Fertil Steril 77 209 215 10.1016/S0015-0282(01)02963-6 11821072 (Pubitemid 34083541)
9. S Franks C Gilling-Smith H Waston D Willis 1999 Insulin action in the normal and polycystic ovary Endocrinol Metab Clin N Am 28 361 378 1:CAS:528:DyaK1MXjsl2mtrk%3D 10.1016/S0889-8529(05)70074-8 (Pubitemid 29242718)
10. JX Wang MJ Daviies RJ Norman 2002 Obesity increases the risk of spontaneous abortion during infertility treatment Obes Res 10 551 554 10.1038/oby.2002.74 12055331
11. RJ Norman MJ Davies J Lord LJ Moran 2002 The role of lifestyle modification in polycystic ovary syndrome Trends Endocrinol Metab 13 251 257 1:CAS:528:DC%2BD38XlsVOktrw%3D 10.1016/S1043-2760(02)00612-4 12128286 (Pubitemid 36733970)
12. J Vrbikova M Hill L Starka K Vondra 2002 Prediction of the effect of metformin treatment in patients with polycystic ovary syndrome Gynecol Obstet Invest 53 100 104 1:CAS:528:DC%2BD38XivVOrur4%3D 10.1159/000053002 11961383 (Pubitemid 34310085)
13. B Baysal M Batukan C Batukan 2001 Biochemical and body weight changes with metformin in polycystic ovary syndrome Clin Exp Obstet Gynecol 28 212 214 1:STN:280:DC%2BD387gslChtw%3D%3D 11838739 (Pubitemid 34154991)
14. R Fleming ZE Hopkinson AM Wallace IA Greer N Sattar 2002 Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in randomized double blind placebo-controlled trial J Clin Endocrinol Metab 87 569 574 1:CAS:528:DC%2BD38XhsVSjurs%3D 10.1210/jc.87.2.569 11836287 (Pubitemid 34158220)
15. S Fujioka Y Matsuzawa K Tokunaga S Tarui 1987 Contribution of intra-abdominal fat accumulation to impairment of glucose and lipid metabolism Metabolism 36 54 59 1:CAS:528:DyaL2sXjtV2nsg%3D%3D 10.1016/0026-0495(87)90063-1 3796297 (Pubitemid 17016386)
16. Matsuzawa Y, Fujioka S, Tokunaga K, Tarui S. A novel classification: visceral fat obesity and subcutaneous fat obesity. In: Berry EM, Blondheim SH, Shafrir EH, editors. Recent advances in obesity research V. London: John Libbey; 1987:92-6.
17. AH Kissenbah GR Krakower 1994 Regional adiposity and morbidity Physiol Rev 74 761 811
18. WY Fujimoto SL Abbate SE Kahn FE Hokanson JD Burunzell 1994 The visceral adiposity syndrome in Japanese-American men Obes Res 2 364 371 1:STN:280:DC%2BD2Mnms1amsA%3D%3D 16353583
19. JP Depres A Nadeau A Tremblay 1989 Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women Diabetes 38 304 309 10.2337/diabetes.38.3.304
20. AH Kissenbah AN Peiris 1989 Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus Diabetes Metab Res 5 83 109 10.1002/dmr.5610050202
21. Matsuzawa Y. Insulin resistance and atherosclerosis. In: Matsuzawa Y, Akanuma Y, editors. Diabetes mellitus, obesity and hyperlipidemia (proceedings of satellite symposium to 15th international diabetes federation congress). Tokyo: Axel Springer; 1995:1-6.
22. A Dunaif J Xia CB Book E Schenker Z Tang 1995 Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome J Clin Invest 96 801 810 1:CAS:528:DyaK2MXnsVagurs%3D 10.1172/JCI118126 7635975
23. DA Ehrmann J Sturis MM Byrne T Karrison RL Rosenfield KS Polonsky 1995 Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus J Clin Invest 96 520 527 1:CAS:528:DyaK2MXmslyqsbY%3D 10.1172/JCI118064 7615824
24. J Holte T Bergh C Berne L Berglund H Lithell 1994 Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance J Clin Endocrinol Metab 78 1052 1058 1:STN:280:DyaK2c3jtVKltw%3D%3D 10.1210/jc.78.5.1052 8175959 (Pubitemid 24143022)
25. Holte J, Bergh T, Berne C, Lithell H. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol (Oxf). 1994;41:463-71.
26. Ciampelli M, Fulghesu AM, Cucunelli F, Pavone V, Caruso A, Mancuso S, Lanzone A. Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod. 1997;12:1897-901.
27. Y Matsuzawa 1997 Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience Diabetes/Metab Rev 13 3 13 1:CAS:528:DyaK2sXjt1Gks70%3D 10.1002/(SICI)1099-0895(199703)13:1<3::AID- DMR178>3.0.CO;2-N (Pubitemid 27213790)
28. RJ Chang RM Nakamura HL Judd SA Kaplan 1983 Insulin resistance in nonobese patients with polycystic ovarian disease J Clin Endocrinol Metab 57 356 359 1:STN:280:DyaL3s3jvVymtA%3D%3D 10.1210/jcem-57-2-356 6223044
29. A Dunaif M Ginf J Mandeli V Laumas A Dobrjansky 1987 Characterization of groups of hyperandrogenemic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia J Clin Endocrinol Metab 65 499 507 1:STN:280:DyaL2szgvVKnsw%3D%3D 10.1210/jcem-65-3-499 3305551
30. A Dunaif KR Segal W Futterweil A Dobrjansky 1989 Profound peripheral insulin resistance independent of obesity in polycystic syndrome Diabetes 38 1165 1174 1:STN:280:DyaL1MzlslartA%3D%3D 10.2337/diabetes.38.9.1165 2670645
31. A Dunaif KR Segal DR Shelley G Green A Dobrjansky T Licholan 1992 Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome Diabetes 41 1257 1266 1:STN:280:DyaK3s%2Fht1CqsQ%3D%3D 10.2337/diabetes.41.10.1257 1397698
32. RL Rosenfield RB Barnes JF Cara AW Licky 1990 Dysregulation of cytochrome P450c17 alpha as the cause of polycystic ovarian syndrome Fertil Steril 53 785 791 1:STN:280:DyaK3c3jsF2rtQ%3D%3D 2185040
33. E Carmina T Koyama L Chang FZ Stanczyk RA Lobo 1992 Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 167 1807 1812 1:STN:280:DyaK3s7htFeqsw%3D%3D 1471702
34. DA Ehrmann RL Rosenfield RB Barnes DF Brigell Z Sheikh 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess N Engl J Med 327 157 162 1:STN:280:DyaK38zgtFCrsQ%3D%3D 10.1056/NEJM199207163270304 1319000
35. RL Barbieri A Makris RW Randall 1986 Insulin stimulates androgen accumulation on incubation of ovarian stroma obtained from women with hyperandrogenism J Clin Endocrinol Metab 62 904 910 1:STN:280: DyaL287mvVOgug%3D%3D 10.1210/jcem-62-5-904 3514651
36. RL Barbien S Smith KJ Ryun 1988 The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism Fertil Steril 50 197 212
37. R Nahum KJ Thong SG Hillier 1995 Metabolic regulation of androgen production by human theca cells in vitro Hum Reprod 10 75 81 1:CAS:528:DyaK2MXktlars7g%3D 10.1093/humrep/10.1.75 7745074
38. DS Willis H Watson HD Mason R Galea M Brincat S Franks 1998 Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome relevance to mechanism anovulation J Clin Endocrinol Metab 83 3984 3991 1:CAS:528:DyaK1cXntlOitL8%3D 10.1210/jc.83.11.3984 9814480
39. RD Murray RM Davison RC Russell 2000 Clinical presentation of PCOS following development of an insulinoma. Case report Hum Reprod 15 86 88 1:STN:280:DC%2BD3c%2FnvFWqug%3D%3D 10.1093/humrep/15.1.86 10611194
40. AM Suikkan VA Koivisto EM Rutanen 1988 Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein J Clin Endocrinol Metab 66 266 272 10.1210/jcem-66-2-266
41. AM Suikkan VA Koivisto R Korstinen 1989 Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin J Clin Endocrinol Metab 68 135 140 10.1210/jcem-68-1-135
42. N Botwood D Hamilton-Fairly D Kiddy 1995 Sex hormone-binding globulin and female reproductive function J Steroid Biochem Mol Biol 53 529 531 1:CAS:528:DyaK2MXnt1Gnurw%3D 10.1016/0960-0760(95)00108-C 7626505
43. S Franks S Robinson D Willis 1996 Nutrition, insulin and polycystic ovary syndrome Rev Reprod 1 47 53 1:CAS:528:DyaK28XntF2msw%3D%3D 10.1530/ror.0. 0010047 9414438
44. SG Hillier 1994 Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis Hum Reprod 9 188 191 1:CAS:528:DyaK2cXjtFGqsro%3D 8027271
45. AM Clark W Ledger C Galletly L Tomlinson F Blaney X Wang RJ Norman 1995 Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women Hum Reprod 10 2705 2712 1:STN:280: DyaK287mtVGhsw%3D%3D 8567797
46. JM Lord IH Flight RJ Norman 2003 Metformin in polycystic ovary syndrome: systematic review and meta-analysis BMJ 327 951 953 1:CAS:528: DC%2BD3sXpsVWktbg%3D 10.1136/bmj.327.7421.951 14576245
47. R Azziz D Ehrmann RS Legro RW Whitcomb R Hanley AG Fereshetian M O'keefe MN Ghazzi 2001 Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial J Clin Endocrinol Metab 86 1626 1632 1:CAS:528:DC%2BD3MXivVClu7c%3D 10.1210/jc.86.4.1626 11297595 (Pubitemid 32374915)
48. F Mcyer M Ipaktchi H Clauser 1967 Specific inhibition of gluconeogenesis by biguanides Nature 213 203 204 10.1038/213203a0
49. N Wollen CJ Bailey 1988 Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin Biochem Pharmacol 37 4353 4358 1:CAS:528:DyaL1MXjtlGrtw%3D%3D 10.1016/0006-2952(88)90617-X 3058129 (Pubitemid 18265758)
50. M Metwally S Amer TC Li WL Ledger 2009 An RCT of metformin versus orlistat for the management of obese anovulatory women Hum Reprod 24 966 975 1:CAS:528:DC%2BD1MXjsFektrg%3D 10.1093/humrep/den454 19095663
51. GR Attia WE Rainey BR Carr 2001 Metformin directly inhibits androgen production in human thecal cells Fertil Steril 76 517 524 1:STN:280: DC%2BD3MvptVWktA%3D%3D 10.1016/S0015-0282(01)01975-6 11532475
52. BM Spiegelman JS Flier 1996 Adipogenesis and obesity: rounding out the big picture Cell 87 377 389 1:CAS:528:DyaK28XmvVOktrg%3D 10.1016/S0092-8674(00) 81359-8 8898192 (Pubitemid 26374313)
53. T Kadowaki T Yamauchi 2005 Adiponectin and adiponectin receptors Endocr Rev 26 439 451 1:CAS:528:DC%2BD2MXltVWru7c%3D 10.1210/er.2005-0005 15897298 (Pubitemid 40686653)
54. T Yamauchi T Kadowaki 2008 Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases Int J Obes (Lond) 32 Suppl 7 S13 S18 1:CAS:528:DC%2BD1MXksl2qsw%3D%3D 10.1038/ijo.2008.233
55. A Ben-Haroush Y Yogev B Fisch 2004 Insulin resistance and metformin in polycystic ovary syndrome Eur J Obstet Gynecol Reprod Biol 115 125 133 1:CAS:528:DC%2BD2cXlslyht78%3D 10.1016/j.ejogrb.2003.11.027 15262344 (Pubitemid 38953028)
56. DJ Jakubowicz M Seppala S Jakubowicz O Rodriguez-Arms A Rivas-Santiago H Koistinen R Koistine JE Nestler 2001 Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome J Clin Endocrinol Metab 86 1126 1133 1:CAS:528: DC%2BD3MXitFWnsbY%3D 10.1210/jc.86.3.1126 11238496 (Pubitemid 32322992)
57. M Seppala L Riittinen M Julkunen R Koistinen T Wahlstrom K Iino H Alfthan UH Stenman ML Huhtala 1988 Structural studies, localization in tissue and clinical aspect of human endometrial proteins J Reprod Fertil Suppl 36 127 141 1:CAS:528:DyaL1cXlvVyjs7k%3D 3057195
58. M Julkunen R Koistinen AM Suikkari M Seppala OA Janne 1990 Identification by hybridization histochemistry of human endometrial cells expressing mRNAs encoding a uterine β-lactogloblin homologue and insulin-like growth factor-binding protein-1 Mol Endocrinol 4 700 707 1:CAS:528:DyaK3cXkslWrs7k%3D 10.1210/mend-4-5-700 1703273
59. AE Bolton AG Pockley KJ Clough EA Mowles RJ Stoker OM Westwood MG Chapman 1987 Identification of placental protein 14 as an immunosuppressive factor in human reproduction Lancet 1 593 595 1:STN:280:DyaL2s7ktleqtg%3D%3D 10.1016/S0140-6736(87)90235-2 2881133
60. M Julkunen R Koiteinen J Sjoberg EM Rutanen T Wahlstrom M Seppala 1986 Secretary endometrium synthesizes placental protein 14 Endocrinology 118 1782 1786 1:CAS:528:DyaL28Xit1ant7k%3D 10.1210/endo-118-5-1782 3516653 (Pubitemid 16106770)
61. N Okamoto A Uchida K Takakura Y Karuya H Kanzaki L Riittinen R Koistinene M Seppala T Mori 1991 Suppression by human placental protein 14 of natural killer cell activity Am J Reprod Immunol 26 137 142 1:STN:280: DyaK3s%2FgtVCgsg%3D%3D 1840727
62. LC Giudice SP Mark JC Irwin 1998 Paracrine actions of insulin-like growth factors and IGF binding protein-1 in non-pregnant human endometrium and at the decidual-trophoblast interface J Reprod Immunol 39 133 148 1:CAS:528: DyaK1cXls1yms7g%3D 10.1016/S0165-0378(98)00018-7 9786458 (Pubitemid 28418419)
63. JI Jones A Gockerman WHJ Busby G Wright DR Glemmons 1993 Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence Proc Natl Acad Sci USA 90 10553 10557 1:CAS:528:DyaK2cXisVehsw%3D%3D 10.1073/pnas.90.22.10553 7504269 (Pubitemid 23347080)
64. L Regan EJ Owen HS Jacobs 1990 Hypersecretion of luteinising hormone, infertility, and miscarriage Lancet 336 1141 1144 1:STN:280: DyaK3M%2FktFaksw%3D%3D 10.1016/0140-6736(90)92765-A 1978024 (Pubitemid 20362903)
65. HR Gray LY Wu 2000 Subfertility and risk of spontaneous abortion Am J Public Health 90 1452 1454 1:STN:280:DC%2BD3cvktFGjtw%3D%3D 10.2105/AJPH.90.9. 1452 10983206
66. HS Liddell K Sowden CM Farquhar 1997 Recurrent miscarriage: screening for polycystic ovaries and subsequent pregnancy outcome Aust NZJ Obstet Gynaecol 37 402 406 1:STN:280:DyaK1c%2FptFGgtA%3D%3D 10.1111/j.1479-828X.1997.tb02447.x
67. DJ Jakubowicz MJ Iuorno S Jakubowicz KA Roberts JE Nestler 2002 Effects of metformin on early pregnancy loss in the polycystic ovary syndrome J Clin Endocrinol Metab 87 524 529 1:CAS:528:DC%2BD38XhsVSjtbY%3D 10.1210/jc.87.2.524 11836280 (Pubitemid 34158214)
68. CJ Glueck P Wang N Goldenberg L Sieve-Smith 2002 Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin Hum Reprod 17 2858 2864 1:CAS:528:DC%2BD38XptFOrtbk%3D 10.1093/humrep/17.11.2858 12407039
69. H Tanaka T Shimabukuro M Shimabukuro 2005 High prevalence of metabolic syndrome among men in Okinawa J Atheroscler Thromb 12 284 288 16205025
70. A Dunaif 2008 Drug insight: insulin-sensitizing drugs in the treatment of polycycstic ovary syndrome-a reappraisal Nat Clin Pract Endocrinol Metab 4 272 283 1:CAS:528:DC%2BD1cXkvFWmt7k%3D 10.1038/ncpendmet0787 18364705 (Pubitemid 351571139)
71. R Mathur CJ Alexander J Yano B Trivax R Azziz 2008 Use of metformin in polycystic ovary syndrome Am J Obstet Gynecol 199 569 609 10.1016/j.ajog.2008. 09.010
72. RJ Norman M Noaks R Wu MJ Davies L Moran JX Wang 2004 Improving reproductive performance in overweight/obese women with effective weight management Hum Reprod 10 267 280 10.1093/humupd/dmh018 (Pubitemid 38744871)
73. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. J Biol Chem. 2001;276(44):41245-54.